Sidewinder Therapeutics: Series B

Develops oligonucleotide therapeutics targeting chronic hepatitis B

Uses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia

Physical AI platform capturing real-world lab science into machine-readable data

Develops biologic therapies for respiratory and infectious diseases